A randomized, open-label, presurgical, window-of-opportunity study comparing the pharmacodynamic effects of the novel oral SERD AZD9496 with fulvestrant in patients with newly diagnosed ER+ HER2(-) primary breast cancer
- Submitting institution
-
Imperial College of Science, Technology and Medicine
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 5625
- Type
- D - Journal article
- DOI
-
10.1158/1078-0432.CCR-19-3387
- Title of journal
- Clinical Cancer Research
- Article number
- -
- First page
- 4242
- Volume
- 26
- Issue
- 16
- ISSN
- 1078-0432
- Open access status
- Not compliant
- Month of publication
- March
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
26
- Research group(s)
-
A - Cancer
- Citation count
- 2
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to carrying out the study and to the organisation of the conduct of the study.
The author helped critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -
